Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
159
NMPA:159
Drug Approvals
Fosaprepitant Dimeglumine for Injection
- Product Name
- 注射用福沙匹坦双葡甲胺
- Approval Number
- 国药准字H20193289
- Approval Date
- Aug 1, 2024
NMPA
Repaglinide and Metformin Hydrochloride Tablets（Ⅰ）
- Product Name
- 瑞格列奈二甲双胍片(Ⅰ)
- Approval Number
- 国药准字H20143248
- Approval Date
- Apr 28, 2024
NMPA
Repaglinide and Metformin Hydrochloride Tablets（II）
- Product Name
- 瑞格列奈二甲双胍片(Ⅱ)
- Approval Number
- 国药准字H20143249
- Approval Date
- Apr 28, 2024
NMPA
Bivalirudin For Injection
- Product Name
- 注射用比伐芦定
- Approval Number
- 国药准字H20140057
- Approval Date
- Mar 25, 2024
NMPA
- Prev
- 1
- 2
- 3
- 4
- 5
- 16
- Next
Clinical Trials
No trials found
News
No news found